Vantage Point Podcast: Inside Bioxyne: The ASX’s Profitable Play on Medicinal Cannabis, MDMA & Psilocybin
In this episode, we sit down with Sam Watson, managing director of Bioxyne (BXN:ASX), to unpack how the company is...
News
Here, we share stories about our research, innovations in biotechnology, partnerships, and the people behind our mission to support better health from within. Stay informed, stay inspired, and explore how Bioxyne continues to advance science for a healthier tomorrow.
ASX Briefs: How GMP MDMA and Psilocybin are reshaping access for treatment-resistant patients
Podcast: ASX Briefs – Sam Watson Interview A 149% revenue surge, first‑to‑market GMP MDMA in Australia, and a plan to...
Biocurious: For Bioxyne chief Sam Watson, pot stock success is more than a funky label
Bioxyne is revelling in its status as one of only a few profitable ASX medical cannabis stocks Regulators are tackling...
Bioxyne Boosts FY26 Outlook on Strong Performance and International Growth
Bioxyne lifts FY26 EBITDA guidance to AUD16.5-19m after record H1 FY2026 with AUD31.3m revenue (+149% YoY); expands capacity, enters UK/Germany/LATAM....
Bioxyne receives first psilocybin order
Medicinal cannabis manufacturer Bioxyne has received its first order of GMP-manufactured psilocybin capsules for investigational use in treatment-resistant depression. The...
The fun-guys at Bioxyne chalk up their first psilocybin order
Bioxyne has plenty of ‘shroom to move after first psilocybin sale. A first mover in making psychedelic medications, Bioxyne (ASX:BXN)...
Health Check: Biotech quarterlies serve up sizzling aces amid a few unforced errors
ASX biotechs are serving up champion performances amid the odd fault or two, as reflected in today’s crop of quarterly...
Bioxyne hits record quarterly revenue
Brisbane manufacturer Bioxyne delivered record quarterly revenue of A$17.2 million in Q2 FY26, a 21% increase on Q1 and a...
High Tide, Village Farms, Bioxyne: Cannabis stocks as beneficiaries of Trump’s regulatory shift?
The US government under President Donald Trump has changed the federal classification of cannabis. While cannabis is not being legalized...